We are live on ! Find out more

776 hedge funds and large institutions have $37.6B invested in Cigna in 2017 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 253 increasing their positions, 285 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

314% more call options, than puts

Call options by funds: $524M | Put options by funds: $126M

52% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 46

8% more funds holding in top 10

Funds holding in top 10: 13 → 14 (+1)

3% more funds holding

Funds holding: 756 → 776 (+20)

0.07% more ownership

Funds ownership: 87.73% → 87.8% (+0.07%)

1% less capital inflows, than outflows

Capital inflows: $2.62B | Capital outflows: $2.64B

11% less repeat investments, than reductions

Existing positions increased: 253 | Existing positions reduced: 285

Holders
776
Holders Change
+20
Holders Change %
+2.65%
% of All Funds
19.29%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.35%
New
70
Increased
253
Reduced
285
Closed
46
Calls
$524M
Puts
$126M
Net Calls
+$398M
Net Calls Change
+$245M

CI Hedge Fund Activity: Q2 2017 in Review

776 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in Cigna (CI) for Q2 2017, worth a combined $37.6B — up 14% from $33B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new CI positions and 46 closed out — a net gain of 24 holders — while 253 added to existing stakes and 285 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $266M. The largest seller was Glenview Capital Management, cutting an estimated $187M.

  • 776 institutional investors held Cigna (CI) as of Q2 2017, up from 756 in Q1 2017.
  • Funds reported $37.6B of Cigna stock for Q2 2017, up 14% quarter-over-quarter.
  • 70 funds opened new Cigna positions in Q2 2017 and 46 closed out, a net change of +24 holders.
  • The largest Cigna buyer in Q2 2017 was T. Rowe Price Associates, an estimated $266M added.
  • The largest Cigna seller in Q2 2017 was Glenview Capital Management, an estimated $187M sold.

Based on aggregated 13F filings for Q2 2017.